Contact Us
Have a comment or question? We want to hear from you. Simply fill out the form below and a NXTpsychedelics representative will get back to you as quickly as possible.
MindBio Therapeutics Scientists Present Landmark Women’s Health Trials, Company to Release Phase 2A Depression Trial Secondary Data This Month
Psychedelics2 days ago
PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
Psychedelics2 days ago
GH Research advances depression therapies, burns cash
Law & Regulation2 days ago
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
Psychedelics3 days ago
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
Psychedelics3 days ago
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
Psychedelics3 days ago
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings
Psychedelics3 days ago
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings
Psychedelics3 days ago
MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
Psychedelics3 days ago
What marijuana reclassification could mean for health treatments
Ketamine3 days ago